Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.

Campos, Susana M

Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia. [electronic resource] - Journal of the National Comprehensive Cancer Network : JNCCN Nov 2005 - 807-16 p. digital

Publication Type: Comparative Study; Journal Article

1540-1405

10.6004/jnccn.2005.0049 doi


Aged
Anemia--chemically induced
Antineoplastic Agents--adverse effects
Blood Transfusion
Cohort Studies
Epoetin Alfa
Erythropoietin--therapeutic use
Female
Hematinics--therapeutic use
Hemoglobins--drug effects
Humans
Male
Middle Aged
Multivariate Analysis
Neoplasms--drug therapy
Quality of Life
Recombinant Proteins
Retrospective Studies
Time Factors
Treatment Outcome